| Pseudomonas aeruginosa (SOUTHEAST Data) | |||||||
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
| ceftazidime | 84.3% n=4373 | 83.6% n=3162 | 85.6% n=2752 | 83.9% n=3177 | 86.7% n=2026 | 90.4% n=845 | 84.7% n=737 |
| cefepime | 79.3% n=2991 | 78.9% n=3737 | 81.7% n=3498 | 80.9% n=3665 | 82.4% n=2152 | 86.2% n=862 | 81.6% n=754 |
| ciprofloxacin | 65.3% n=3681 | 66.6% n=2907 | 69.1% n=3202 | 67.9% n=3513 | 67.3% n=2076 | 64% n=750 | 64.3% n=754 |
| ofloxacin | 51.7% n=606 | ||||||
| levofloxacin | 61.7% n=2675 | 64.2% n=2511 | 67.7% n=2028 | 63.9% n=1995 | 63.4% n=1112 | 64.5% n=862 | 63.9% n=754 |
| gatifloxacin | 62.5% n=1019 | 67.1% n=359 | 67.4% n=460 | 65.6% n=163 | |||
| gentamicin | 73.1% n=4572 | 76.6% n=4351 | 77.4% n=3621 | 76.8% n=3717 | 80.1% n=2199 | 79.2% n=862 | 76.7% n=754 |
| tobramycin | 86.5% n=4572 | 89.2% n=4125 | 90.7% n=3382 | 88.9% n=3625 | 89.9% n=2089 | 89.2% n=862 | 86.7% n=754 |
| amikacin | 94.3% n=3051 | 95.5% n=2927 | 95.1% n=2932 | 94.1% n=3070 | 94.9% n=1532 | 95.5% n=584 | 91.9% n=531 |
| aztreonam | 63.8% n=2891 | 63.3% n=3364 | 68.4% n=2748 | 67.3% n=2967 | 65.9% n=1386 | 71.3% n=862 | 68.4% n=753 |
| meropenem | 85% n=856 | 87.9% n=439 | 93.7% n=526 | 86.4% n=140 | 89.6% n=1297 | 86.7% n=534 | 80.6% n=521 |
| imipenem | 82.9% n=4572 | 82.8% n=3957 | 86.7% n=3281 | 85.3% n=3669 | 85.7% n=2153 | 83.6% n=862 | 81.7% n=754 |
| piperacillin | 92.6% n=637 | 92.1% n=706 | 97.6% n=126 | 97.1% n=137 | 98.6% n=71 | ||
| pip/taz | 91.5% n=4349 | 92% n=3993 | 93.5% n=3500 | 92.9% n=3669 | 93.3% n=2026 | 88.7% n=862 | 91.9% n=754 |
| Totals | 79.2% n=39826 | 79.8% n=37198 | 82.3% n=31955 | 80.9% n=33804 | 82.4% n=20282 | 81.4% n=8747 | 78.9% n=7820 |
This data is accurate as of: 11/22/2016 11:54:02 AM
Drugs with less than 10 isolates are removed from the chart and from the graph. The following drugs had some data removed: piperacillin.
